Human Epidermal Growth Factor Receptor 2 (HER-2) Status in Gastric and Gastro-Esophageal Junction (GEJ) Carcinoma

NCT02731313 · clinicaltrials.gov ↗

COMPLETED

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer, Gastroesophageal Junction Cancer

Interventions

BIOLOGICAL: Trastuzumab

Sponsor

Hoffmann-La Roche